Publication | Open Access

Assessment of Immune-Related Interstitial Lung Disease in Patients With NSCLC Treated with Immune Checkpoint Inhibitors: A Multicenter Prospective Study

Autoimmune DiseaseMulticenter Prospective StudyAdvanced Lung DiseaseMedicineImmune Checkpoint InhibitorsImmunologyImmune Checkpoint InhibitorPulmonary FibrosisNsclc TreatedImmunotherapyOncologyRadiation OncologyMatrikinesLung CancerPulmonary Disease